AIM ImmunoTech Inc

AIM

Latest QuantConomy context for AIM: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class

stock

Primary venue

AMEX

Recent signals

SEC filings

Asset profile

QuantConomy has a structured record for AIM. More descriptive asset metadata will appear here when the platform record includes it.

Latest signal rows

Recent signals for AIM

Scored rows are pulled from the same signal API used by the digests.

Signal	Direction	Score	Observed	Reason
fundamental operating income change	very bullish	76	May 15, 12:00 AM	AIM (Q1 2026, operating income): grew 80.9% (-$11.66M → -$2.23M). [sequential period basis, very bullish signal]
fundamental eps change	very bullish	76	May 15, 12:00 AM	AIM (Q1 2026, diluted eps): EPS grew 92.0% ($-8.62 → $-0.69). [sequential period basis, very bullish signal]
earnings earnings release	neutral	40	May 19, 12:00 AM	AIM filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-05-19. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read).

FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.

EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).

Market	Exchange	Source	Asset record
AIM	AMEX	fmp	AIM ImmunoTech Inc.
AIM	AMEX	alpaca	AIM ImmunoTech Inc.

Buys, last 90d

Sells, last 90d

Rows

No recent Form 3, 4, or 5 insider transaction rows were returned for AIM.

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.